Pieter‐Jan van Dam

Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial

Thomas Powles, Mark Kockx, Alejo Rodríguez‐Vida et al. · Nature Medicine · 2019 · 571 citations · Full text

Medicine, Oncology, Urology +13

International consensus guidelines for scoring the histopathological growth patterns of liver metastasis

Pieter‐Jan van Dam, Eric P. van der Stok, Laure-Anne Teuwen et al. · British Journal of Cancer · 2017 · 232 citations · Full text

Medicine, Oncology, Pathology +17

Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder

Bernadett Szabados, Mark Kockx, Zoe J. Assaf et al. · European Urology · 2022 · 190 citations · Full text

Medicine, Oncology, Urology +13

<i>TP53</i> Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer

Bram De Laere, Steffi Oeyen, Markus Mayrhofer et al. · Clinical Cancer Research · 2018 · 171 citations · Full text

Medicine, Oncology, Pharmacology +17

Comprehensive Profiling of the Androgen Receptor in Liquid Biopsies from Castration-resistant Prostate Cancer Reveals Novel Intra-AR Structural Variation and Splice Variant Expression Patterns

Bram De Laere, Pieter‐Jan van Dam, Tom Whitington et al. · European Urology · 2017 · 141 citations

Medicine, Molecular Biology, Oncology +17